Provided by Tiger Fintech (Singapore) Pte. Ltd.

ODDITY Tech Ltd.

61.44
+14.3130.36%
Post-market: 61.440.00000.00%16:00 EDT
Volume:6.78M
Turnover:389.72M
Market Cap:3.43B
PE:37.40
High:62.07
Open:51.22
Low:49.23
Close:47.13
Loading ...

Stock Track | Oddity Tech Soars 20.94% in Pre-market Following Strong Q1 Earnings Beat and Raised 2025 Outlook

Stock Track
·
Yesterday

Top Midday Gainers

MT Newswires Live
·
2 hours ago

Stock Track | Oddity Tech Soars 21% on Strong Q1 Earnings and Raised 2025 Outlook

Stock Track
·
Yesterday

Oddity Tech Shares up 12% After Co Raises Annual REV, Profit Forecast

THOMSON REUTERS
·
Yesterday

BUZZ-Oddity Tech surges on beat-and-raise report despite tariffs

Reuters
·
Yesterday

Oddity Tech Shares up 18.8% Premarket After Co Raises Annual REV, Profit Forecast

THOMSON REUTERS
·
Yesterday

Oddity Tech Q1 Adjusted Earnings, Revenue Rise; 2025 Outlook Raised -- Shares Climb

MT Newswires Live
·
Yesterday

Oddity Tech Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Yesterday

Oddity Tech (ODD) Q1 Earnings and Revenues Beat Estimates

Zacks
·
Yesterday

Earnings Flash (ODD) Oddity Tech Q1 Net Revenue $268.1 Million vs. FactSet Est $260.6 Million

MT Newswires Live
·
Yesterday

Earnings Flash (ODD) Oddity Tech Q1 Adjusted EPS $0.69 vs. FactSet Est $0.62

MT Newswires Live
·
Yesterday

ODDITY Tech Q1 Adj. EPS $0.69 Beats $0.62 Estimate, Sales $268.08M Beat $260.69M Estimate

Benzinga
·
Yesterday

Oddity Tech Reports Record First Quarter Results, Raises Full Year Outlook

THOMSON REUTERS
·
Yesterday

Oddity Tech Outlook FY Gross Margin 71%

THOMSON REUTERS
·
Yesterday

Oddity Tech Q1 EPS USD 0.63

THOMSON REUTERS
·
Yesterday

Press Release: ODDITY Tech Reports Record First Quarter Results, Raises Full Year Outlook

Dow Jones
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
29 Apr

Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025

GlobeNewswire
·
23 Apr

ODDITY Tech Is Maintained at Overweight by JP Morgan

Dow Jones
·
22 Apr

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

GlobeNewswire
·
22 Apr